Martinez-Vicente M, Talloczy Z, Kaushik S, et al. Dopaminemodified alpha-synuclein blocks chaperone-mediated autophagy[J]. J Clin Invest, 2008, 118(2):777.
[2]
Pan T, Kondo S, Le W, et al. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson\'s disease[J]. Brain, 2008, 131:1969.
[3]
Shacka J J, Roth K A, Zhang J H. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy[J]. Front Biosci, 2008, 13:718.
[4]
Boya P, Gonzalez-Polo R A, Casares N, et al. Inhibition of macroautophagy triggers apoptosis[J]. Mol Cell Biol, 2005, 25:1025.
[5]
Krüger R, Kuhn W, Müller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\'s disease[J]. Nat Genet, 1998, 18(2):106.
[6]
Cuervo A M, Dice J F. Regulation of lamp2a levels in the lysosomal membrane[J]. Traffic, 2000, 1:570.
[7]
Yang Q, She H, Gearing M, et al. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy[J]. Science, 2009, 323:124.
[8]
Massey A C, Kaushik S, Sovak G, et al. Consequences of the selective blockage of chaperone-mediated autophagy[J]. Proc Natl Acad Sci USA, 2006, 103(15):5805.
[9]
Klionsky D J, Abeliovich H, Agostinis P, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes[J]. Autophagy, 2008, 4:151.
[10]
Winkler S, Hagenah J, Lincoln S, et al. Alpha-synuclein and Parkinson disease susceptibility[J]. Neurology, 2007, 69(18):1745.
[11]
Betarbet R, Sherer T. Ubiquitin-proteasome system and Parkinson\'s diseases[J]. Exp Neurol, 2005, 191(Suppl):S17.
[12]
Kiffin R, Christian C, Knecht E, et al. Activation of chaperone-mediated autophagy during oxidative stress[J]. Mol Biol Cell, 2004, 15:4829.
[13]
Dice J F. Chaperone-mediated autophagy[J]. Autophagy, 2007, 3(4):295.
[14]
Klionsky G J, Emr S D. Autophagy as a regulated pathway of cellular degradation[J]. Science, 2000, 290:1717.
[15]
Sarkar S, Ravikumar B, Rubinsztein D C. Autophagic clearance of aggregate-prone proteins associated with neurodegeneration[J]. Methods Enzymol, 2009, 453:83.
Zhu G Q, Wang X C, Wu S B, et al. Involvement of activation of PI3K/Akt pathway in the protective effects of puerarin against MPP+-induced p53-dependent apoptosis[J]. Neurochem Int, 2012, 60(4):400.
[18]
Zhu G Q, Wang X C, Chen Y F, et al. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of parkinson\'s disease[J]. Planta Med, 2010, 76(16):1820.
[19]
Cheng Y F, Zhu G Q, Wang M, et al. Involvement of ubiquitin proteasome system in protective mechanisms of puerarin to MPP+-elicited apoptosis[J]. Neurosci Res, 2009, 63(1):52.
[20]
Kiffin R, Christian C, Knecht E, et al. Activation of chaperone-mediated autophagy during oxidative stress[J]. Mol Biol Cell, 2004, 15(11):4829.
[21]
Robbins E, Marcus P I. Dynamics of acridine orange-cell interaction. I. Interrelationships of acridine orange particles and cytoplasmic reddening[J]. J Cell Biol, 1963, 18:237.
[22]
Rubinsztein D C. The roles of intracellular protein-degradation pathways in neurodegeneration[J]. Nature, 2006, 443:780.
[23]
Zhu G Q, Wang X C, Wu S B, et al. Neuroprotective effects of puerarin on MPTP-induced Parkinson\'s disease model in mice[J]. Phytother Res, 2013, doi: 10.1002/ptr.4975.
